Áٱ⼼Æ÷ÁÖ ÀºÇà
¼¼Æ÷ÁÖ °Ë»ö
µî·ÏµÈ Àΰ£ ¹è¾ÆÁٱ⼼Æ÷ÁÖ
µî·ÏµÈ Àΰ£ ¿ªºÐÈ­ À¯µµ¸¸´ÉÁٱ⼼Æ÷ÁÖ
¿ªºÐÈ­ Áٱ⼼Æ÷ÁÖÀÇ ÇüÅÂ
¿ªºÐÈ­ Áٱ⼼Æ÷ÁÖÀÇ Áúº´¿¡ ´ëÇÑ ¼³¸í
¼¼Æ÷Áֺоç
ºÐ¾ç¾È³»
¼¼Æ÷ÁÖ µî·Ï
µî·Ï¾È³»
´ëÇ¥Àû ¼¼Æ÷ÁÖ °ËÁõ
ID  
PW
ID/PW ã±â ¾ÆÀ̵ð ÀúÀå
Home ȸ¿ø°¡ÀÔLogin Sitemap Contact us Contact us
Home>Áٱ⼼Æ÷ ÀºÇà>¼¼Æ÷ÁÖ°Ë»ö
Table. iPS Cells Derived from Somatic Cells of Patients with Diseases
Name Disease Genetic Defect Donor Cell Age Sex
PD Parkinson's disease
ÆÄŲ½¼º´
Multifactorial
(Sporadic)
Fibroblast 53YR Male
AD Alzheimer's disease
¾ËÃ÷ÇÏÀ̸Ӻ´
25% at risk
for Alzheimer's disease
(Familial)
Fibroblast 18YR Male
JDM Juvenile-onset, type ¥° diabetes mellitus
Àν¶¸° ÀÇÁ¸Çü ´ç´¢º´
(¼Ò¾ÆÇü ´ç´¢º´)
IDDM1 gene defect
(Familial)
Fibroblast 20YR Male
DMD Duchenne type
muscular dystrophy
µÚ¼ÏÇü ±ÙÀÌ¿µ¾çÁõ
Multifactorial
(Sporadic)
Fibroblast 15YR Male
CCALD Adrenoleukodystrophy
CCALD type
¼Ò¾Æ´ë³úÇü
ºÎ½Å¹éÁúÀÌ¿µ¾çÁõ
ABCD1 gene defect Fibroblast 6YR Male
AMN Adrenoleukodystrophy
AMN type
ºÎ½Åô¼ö½Å°æº´
ºÎ½Å¹éÁúÀÌ¿µ¾çÁõ
ABCD1 gene defect Fibroblast 32YR Male
WT Human Dermal Fibroblasts, neonatal
(Isolated from neonatal foreskin)
Àΰ£ ÇǺμ¶À¯¾Æ¼¼Æ÷, ½Å»ý¾ÆÇü (Á¤»óÀÎ)
NA Fibroblast Neonatal Male
ÆÄŲ½¼º´(PD; Parkinson's disease)
³úÀÇ ÈæÁú(substantia nigra)¿¡ ºÐÆ÷ÇÏ´Â µµÆÄ¹Î ºÐºñ ½Å°æ¼¼Æ÷°¡ Á¡Â÷ ¼Ò½ÇµÇ¾î ¹ß»ýÇϸç, ¾ÈÁ¤¶³¸², °æÁ÷, ¿îµ¿´À¸² ¹× ÀÚ¼¼ ºÒ¾ÈÁ¤¼ºÀÌ Æ¯Â¡ÀûÀ¸·Î ³ªÅ¸³ª´Â ½Å°æ°èÀÇ ¸¸¼º ÁøÇ༺ ÅðÇ༺ ÁúȯÀÌ´Ù. ÆÄŲ½¼º´ÀÇ ¿øÀÎÀº ¾ÆÁ÷±îÁö ¹àÇôÁöÁö ¾Ê¾ÒÁö¸¸, ÇöÀç À¯ÀüÀû ÀÎÀÚ¿Í È¯°æÀû ÀÎÀÚ°¡ ¼­·Î »óÈ£ÀÛ¿ëÀ» ÀÏÀ¸Å²´Ù´Â '´ÙÀμº °¡¼³'ÀÌ °¡Àå º¸ÆíÀûÀ¸·Î ¹Þ¾Æµé¿©Áø´Ù. 53¼¼ ȯÀÚÀÇ ¼¶À¯¾Æ¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿© À¯µµ¸¸´ÉÁٱ⼼Æ÷¸¦ È®¸³ÇÏ¿´´Ù.
¾ËÃ÷ÇÏÀ̸Ó(AD;Alzheimer's disease)
¾ËÃ÷ÇÏÀ̸Ӵ Ãʷμº Ä¡¸Å(Presenile dementia)¿Í ³ëÈ­¼º Ä¡¸Å(senile dementia)·Î ³ª´µ´Âµ¥, ±×Áß¿¡ Ãʷμº Ä¡¸Å´Â 65¼¼ ÀÌÀü¿¡ ¹ßº´ÇÏ¸ç ½Ç¾îÁõ, ½ÇÇàÁõ, ½ÇÀÎÁõµîÀÇ Áõ»óÀ» °¡Áø´Ù. ¿ì¸®°¡ »ç¿ëÇÑ ¼¼Æ÷´Â °¡Á·¿¡ ÀÇÇØ À¯ÀüµÇ¾î ¹ß»ýÇÑ 18»ìÀÇ ¾ËÃ÷ÇÏÀ̸ÓÇü Ãʷμº Ä¡¸ÅÀÇ È¯ÀڷκÎÅÍ ¾òÀº ¼¶À¯¾Æ¼¼Æ÷ÀÌ´Ù.
µÚ¼ÏÇü ±ÙÀÌ¿µ¾çÁõ(DMD; Duchenne Muscular Dystrophy)
¼º¿°»öüÀÎ X¿°»öüÀÇ dystrophin À¯ÀüÀÚ¿¡ µ¹¿¬º¯À̰¡ ÀϾ ¹ß»ýÇÏ´Â Áúº´ÀÌ´Ù. ¾Æµ¿¿¡°Ô ¹ß»ýÇÏ´Â ±ÙÀ§Ãà Áß °¡Àå ÈçÇÑ ÇüÅ·Πº¸Åë 2¼¼¿¡¼­ 5¼¼¿¡ º¸ÇàÀå¾Ö°¡ ¹ß°ßµÇ¸ç ÁøÇ༺ ±Ù·Â ÀúÇϸ¦ º¸ÀÌ´Ù°¡ 30¼¼ ÀÌÀü¿¡ »ç¸ÁÇÑ´Ù. 15¼¼ ȯÀÚÀÇ ¼¶À¯¾Æ¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿© À¯µµ¸¸´É Áٱ⼼Æ÷¸¦ È®¸³È÷¿´´Ù.
Á¦ 1Çü ¼Ò¾Æ´ç´¢(JDM;Juvenile-onset diabetes mellitus)
´ç´¢¿¡´Â ¼Ò¾Æ´ç´¢(Á¦1Çü´ç´¢), ¼ºÀδ索(Á¦2Çü´ç´¢)·Î ³ª´­ ¼ö Àմµ¥, Á¦ 1Çü ´ç´¢ÀÇ °æ¿ì ÃéÀå¿¡¼­ Àν¶¸° ºÐºñ°¡ µÇÁö ¾Ê¾Æ ´çºÐÀÇ ºÐÇØ ´É·ÂÀÌ ÀüÇô ¾ø´Â °æ¿ì¸¦ ¸»Çϸç, ÁÖ·Î ¾î¸°À̳ª û¼Ò³âµéÀÌ ¸¹ÀÌ ¹ßº´ÇÑ´Ù.
¿ì¸®°¡ »ç¿ëÇÑ ¼¼Æ÷´Â 4»ìºÎÅÍ Áõ»óÀÌ ½ÃÀÛµÈ 20»ì ȯÀÚÀÇ ¼¶À¯¾Æ¼¼Æ÷ÀÌ´Ù.
ºÎ½Å¹éÁúÀÌ¿µ¾çÁõ, ¼Ò¾Æ´ë³úÇü(CCALD; Childhood Cerebral Adrenoleukodystrophy)
·Î·»Á¶ ¿ÀÀϺ´À̶ó°íµµ ºÒ¸®´Â ÀÌ Áúº´Àº ¼º¿°»öüÀÎ X¿°»öü¿¡ À§Ä¡ÇÏ´Â ABCD1 À¯ÀüÀÚÀÇ ÀÌ»óÀ¸·Î ±ä»ç½½ Áö¹æ»ê(VLCFAs; very long chain fatty acids)ÀÌ ºÐÇØµÇÁö ¾Ê°í ƯÈ÷, ½Å°æ°è¿Í ºÎ½Å¿¡ ÃàÀûµÇ¾î ÆÄ±«ÇÏ´Â ´ë»çÀå¾ÖÀÌ´Ù. ƯÈ÷ ³ú¿¡¼­´Â ¿°Áõ¹ÝÀÀÀÌ µ¿¹ÝÇÑ´Ù. 5~10¼¼ÀÇ ³²ÀÚ ¾î¸°ÀÌ¿¡°Ô¼­ ù Áõ»óÀÌ ³ªÅ¸³­ ÈÄ 2³â À̳»¿¡ »ç¸ÁÇÏ°Ô µÈ´Ù. 6¼¼ ȯÀÚ¿¡°Ô¼­ ¾òÀº ¼¶À¯¾Æ¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿© À¯µµ¸¸´ÉÁٱ⼼Æ÷¸¦ ¾ò¾ú´Ù.
ºÎ½Åô¼ö½Å°æº´Çü (AMN; Adrenomyeloneuropathy)
ALDÁúº´ ŸÀÔÁß Çϳª·Î¼­, 28+/-9¼¼¿¡ Áõ»óÀÌ ½ÃÀ۵Ǹç, ¼ö½Ê ³â¿¡ °ÉÃÄ ÁøÇàµÈ´Ù. ÁַΠô¼ö¸¦ ħ¹üÇÏ°í ¿°ÁõÀº ¼Ò·® ȤÀº ¾ø´Ù. 45%´Â ¿°Áõ ¹ÝÀÀ°ú ÇÔ²² ´Ù¾çÇÑ ´ë³ú ħ¹üÀÌ °¡´ÉÇÏ´Ù. ¿ì¸®°¡ »ç¿ëÇÑ ¼¼Æ÷´Â ABCD1 geneÀÇ exon 8-10 ÀÌ °á¼ÕµÇ¾î ÀÖ´Â 32»ì ȯÀÚÀÇ ¼¶À¯¾Æ¼¼Æ÷ÀÌ´Ù.
Á¤»ó ¼¶À¯¾Æ¼¼Æ÷ (HDFn; Human dermal fibroblasts, neonatal)
Áúº´ÀÌ ¾ø´Â ½Å»ý¾ÆÀÇ Ç¥ÇǷκÎÅÍ ºÐ¸®µÈ ¼¶À¯¾Æ¼¼Æ÷¸¦ »ç¿ëÇÏ¿´´Ù.
Áٱ⼼Æ÷ÁÖ°ËÁõ¹×°ü¸®Ã¼°è Áٱ⼼Æ÷ÁÖÀºÇà °ü·Ã¼­½Ä °ü·Ã»çÀÌÆ® Á¤º¸¸¶´ç